Literature DB >> 16413636

[The cochlea in Fabry disease: a sensorineural hearing loss model of vascular origin?].

D Malinvaud1, P Avan, D P Germain, K Benistan, P Bonfils.   

Abstract

PURPOSE: Fabry disease is an inborn error of metabolism due to a deficient activity of the lysosomal enzyme alpha-galactosidase A. The enzyme defect leads to the systemic accumulation of neutral glycosphingolipids in tissues, mainly in the vascular endothelium. STRONG POINT: The aim of this paper is to present a review of the auditory manifestations in Fabry disease, and to discuss hypothesis on the vascular origin of deafness. PERSPECTIVES: Sensorineural hearing loss in Fabry disease could be the first documented vascular pathology of the inner ear.

Entities:  

Mesh:

Year:  2006        PMID: 16413636     DOI: 10.1016/j.revmed.2005.12.006

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  3 in total

1.  Hearing loss in a family affected by Fabry disease.

Authors:  Bruno Sergi; Guido Conti
Journal:  J Inherit Metab Dis       Date:  2007-05-09       Impact factor: 4.982

2.  Fabry disease and hearing loss. Comment on: Barras FM, Maire R (2006) Progressive hearing loss in Fabry's disease: a case report. Eur Arch Otorhinolaryngol 263:688-691.

Authors:  Bruno Sergi; Guido Conti
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-11-24       Impact factor: 2.503

3.  Cochleovestibular involvement in patients with Fabry disease: data from the multicenter cohort FFABRY.

Authors:  Antoine Asquier-Khati; Wladimir Mauhin; Guillaume Michel; Adrien Gendre; Cécile Durant; Christian Lavigne; Hélène Maillard; Didier Lacombe; Marjolaine Willems; Olivier Lidove; Agathe Masseau
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-11-26       Impact factor: 2.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.